Oxalic Acid

Oxalic Acid

SCHEMBL7324613

CCCCCN1CCCCC1CCOc1ccc(Cl)c(Cl)c1.O=C(O)C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.58
KDM4E B2RXH2 7/20 0.58
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
POLB P06746 2/20 0.55
HCRTR2 O43614 2/20 0.54
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CHEK2 O96017 1/20 0.46
LMNA P02545 1/20 0.46
LTA4H P09960 2/20 0.46
THRB P10828 1/20 0.46
HRH3 Q9Y5N1 1/20 0.45
S1PR4 O95977 1/20 0.44
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
S1PR5 Q9H228 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327714 0.95 HCRTR1 (0.55) HCRTR1KDM4EALDH1A1SMN1; SMN2POLB
Oxalic Acid SCHEMBL7324624 0.85 HCRTR1 (0.52) HCRTR1KDM4EALDH1A1HCRTR2MEN1
Oxalic Acid SCHEMBL7321680 0.83 FAAH (0.49) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
Oxalic Acid SCHEMBL7359206 0.81 LTA4H (0.55) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
Oxalic Acid SCHEMBL7359209 0.81 LTA4H (0.55) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
Oxalic Acid SCHEMBL7330044 0.81 MAOB (0.49) SMN1; SMN2LMNAHRH3
SCHEMBL11447662 0.80 LTA4H (0.53) LTA4HHRH3
Oxalic Acid SCHEMBL9697739 0.79 KDM4E (0.63) KDM4EALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL7329491 0.79 MEN1 (0.50) HCRTR1ALDH1A1HCRTR2MEN1KMT2A
SCHEMBL7328727 0.78 FAAH (0.51) KDM4EALDH1A1MEN1KMT2AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629190-A1 COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-12-21 EP disclosed
WO-1993015052-A1 COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-08-05 WO disclosed